Dejun Xuan
Pfizer (United States)(US)
Publications by Year
Research Areas
Cytokine Signaling Pathways and Interactions, Rheumatoid Arthritis Research and Therapies, Systemic Lupus Erythematosus Research, Invertebrate Immune Response Mechanisms, Studies on Chitinases and Chitosanases
Most-Cited Works
- → Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition(2016)189 cited
- → Sources of NADPH and Expression of Mammalian NADP+-specific Isocitrate Dehydrogenases in Saccharomyces cerevisiae(1998)81 cited
- → Selective functional inhibition of JAK‐3 is sufficient for efficacy in collagen‐induced arthritis in mice(2010)74 cited
- → Kinetic Characterization of Recombinant Human Acidic Mammalian Chitinase(2006)67 cited
- → Local delivery of granulocyte macrophage colony-stimulating factor by retrovirally transduced antigen-specific T cells leads to severe, chronic experimental autoimmune encephalomyelitis in mice(2002)41 cited
- → Evolutionary and biochemical differences between human and monkey acidic mammalian chitinases(2009)34 cited
- → The novel and selective JAK3 inhibitor WYE-152038 is highly efficacious in a mouse model of rheumatoid arthritis(2009)